Australian Pharmaceutical Advisory Council

Augmedix Establishes AI Advisory Council to Guide the Company’s Continued Development of High Standard, Responsible Product Development

Retrieved on: 
Lunedì, Giugno 12, 2023
Executive, Harvard University, History, Privacy, Doctor of Philosophy, Advisory Council, Trust, SM, Patient, SAN, Machine learning, Algorithm, Council, Computer graphics, AI, Computer science, Australian Pharmaceutical Advisory Council, Medical device, Health

The healthcare industry’s adoption of AI is growing very rapidly and Augmedix is committed to harnessing the power of AI thoughtfully and responsibly to provide its customers with solutions they can trust.

Key Points: 
  • The healthcare industry’s adoption of AI is growing very rapidly and Augmedix is committed to harnessing the power of AI thoughtfully and responsibly to provide its customers with solutions they can trust.
  • The Advisory Council will provide advice and guidance to the Augmedix senior leadership team on matters related to the integration of AI into the Company’s product development roadmap.
  • Members of the council will include distinguished industry thought leaders from computer science, bioinformatics, digital healthcare, as well as Augmedix customers.
  • This Council is a good step forward in securing the principles of transparency, trust, accountability, privacy, and security in Augmedix’s suite of products.”

Firefly Health Launches Advisory Council to Support Business Growth and Product Expansion

Retrieved on: 
Martedì, Aprile 11, 2023
Professional Services, Health, Thought Leadership, Telemedicine, Virtual Medicine, Hospitals, Insurance, Health Insurance, Face, Cigna, PepsiCo, Consultant, Government, Advisory Council, Patient, Australian Pharmaceutical Advisory Council, Council, Growth, Commonwealth, Wellness, Pharmaceutical industry, Health insurance, Management, Firefly

The council will provide Firefly Health with outside perspectives and guidance around the company’s benefit, product and growth strategy.

Key Points: 
  • The council will provide Firefly Health with outside perspectives and guidance around the company’s benefit, product and growth strategy.
  • “Our powerhouse Advisory Council brings decades of expertise in tackling some of employers’ biggest pain points around employee care and cost.
  • Their experience and expansive professional networks bring valuable perspective to the next phase of Firefly,” said Firefly CEO, Fay Rotenberg.
  • Members of the Advisory Council include:
    Brian Marcotte, former President and CEO, National Business Group on Health; Firefly Health Advisory Council Chairman
    Ron Fontenetta, former North America Health and Benefits Practice Leader of Strategic Growth, Willis Tower Watson
    Matt Manders, former President of Government and Solutions, Cigna Corporation
    Eric Sossa, former Vice President of Global Benefits and Wellness, PepsiCo
    “I am thrilled to support a company addressing some of our country’s deepest pain points in healthcare,” said Brian Marcotte, Firefly Health Advisory Council Chairman.

Government Must Not Break Their Promise and Leave Canadians Paying Sky-High Drug Costs

Retrieved on: 
Venerdì, Aprile 15, 2022
Investment, Bruske, Affiliated unions of the Canadian Labour Congress, Australian Pharmaceutical Advisory Council, Government, Medicine, Advisory Council, GLOBE, Implementation, Congress, Pharmaceutical industry

We are calling on the government: dont break your promise to Canadians.

Key Points: 
  • We are calling on the government: dont break your promise to Canadians.
  • We can't count on big pharmaceutical corporations to stand up for Canadians, that's the job of our governments, said Bea Bruske, President of the Canadian Labour Congress.
  • The Advisory Council on the Implementation of National Pharmacare made clear that strengthening thePatented Medicines Regulationsis absolutely essential to lowering drug prices and moving towards National Pharmacare.
  • Too many medicines are unaffordable and the new PMPRB framework could have saved Canadians approximately $13.2 billion over 10 years.

New Advisory Council Gives VITAL WorkLife Expanded Strategic Direction Supporting Emotional Health of Employees and Healthcare Workers

Retrieved on: 
Martedì, Gennaio 18, 2022
Well, Patient, FAAFP, Australian Pharmaceutical Advisory Council, Consultant, Bachelor of Arts, University, COVID-19, MBA, Practice, Ageing, Wellness, CEO, Faculty, Master, Solution, American Medical Group Association, VITAL, Well-Being Index, Industry, Goal, Northwestern Medicine, The Principles and Practice of Medicine, Northwestern University, Advisory Council, PJ, MD, Public administration, Workforce, Sutter Health, Peer, Bachelor, Organization, Physician, Pharmaceutical industry, Medicine, Management, Medicine

MINNEAPOLIS, Jan. 18, 2022 /PRNewswire/ -- VITAL WorkLife , the national leader in behavioral health consulting to professionals and organizations in the healthcare industry, announced it has launched an Advisory Council of industry leaders.

Key Points: 
  • MINNEAPOLIS, Jan. 18, 2022 /PRNewswire/ -- VITAL WorkLife , the national leader in behavioral health consulting to professionals and organizations in the healthcare industry, announced it has launched an Advisory Council of industry leaders.
  • VITAL WorkLife's focus on the emotional and behavioral well being of physicians and healthcare teams, has made it the national leader in comprehensive well being solutions designed specifically for healthcare.
  • Workers in the US healthcare industry, considered the best in the world, require special programs which focus on their unique needs.
  • The intensity of behavioral and emotional health issues for physicians has emerged as a secondary pandemic as a result of COVID-19.